Nektar Therapeutics | NKTR - Assets


Nektar Therapeutics reported $280.41M in Assets for its fiscal quarter ending in December of 2025.





Assets Change Date
Agios Pharmaceuticals USD 1.18B 112.24M Mar/2026
ALKERMES USD 4.26B 1.77B Mar/2026
Alterity Therapeutics Limited AUD 37.98M 15.78M Dec/2025
Amgen USD 92.5B 1.92B Mar/2026
Baxter International USD 19.85B 209M Mar/2026
BioCryst Pharmaceuticals USD 514.16M 67.73M Dec/2025
Biogen USD 29.48B 43.6M Mar/2026
Bristol-Myers Squibb USD 86.48B 3.56B Mar/2026
Cara Therapeutics USD 39.02M 4.73M Sep/2025
Cipla INR 401.64B 27.77B Sep/2025
Dr.Reddys Laboratories INR 562.9B 20.89B Dec/2025
Eisai JPY 1.49T 48.22B Dec/2025
Eli Lilly USD 116.58B 4.1B Mar/2026
Esperion Therapeutics USD 465.89M 101.87M Dec/2025
Exelixis USD 2.84B 20.87M Dec/2025
Gilead Sciences USD 59.02B 490M Dec/2025
GlaxoSmithKline GBP 62.87B 1.75B Mar/2026
Grifols EUR 23.15B 142.7M Dec/2025
Halozyme Therapeutics USD 2.53B 304.09M Dec/2025
Incyte USD 7.34B 381.14M Mar/2026
Ionis Pharmaceuticals USD 3.45B 74M Mar/2026
Ironwood Pharmaceuticals USD 396.06M 53.12M Sep/2025
Karyopharm Therapeutics USD 108.42M 12.18M Dec/2025
MacroGenics USD 256.85M 13.92M Dec/2025
Merck USD 128.68B 8.18B Mar/2026
Nektar Therapeutics USD 280.41M 20.94M Dec/2025
Neurocrine Biosciences USD 4.91B 274.7M Mar/2026
Novartis USD 118.53B 7.58B Mar/2026
Pfizer USD 207.62B 542M Mar/2026
Roche Holding CHF 100.7B 5.94B Dec/2025
Sarepta Therapeutics USD 3.35B 143.73M Dec/2025
Takeda JPY 15.41T 938.47B Dec/2025
Teva Pharmaceutical Industries USD 40.04B 708M Mar/2026
Xencor USD 875.5M 6.68M Dec/2025